<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02587013</url>
  </required_header>
  <id_info>
    <org_study_id>151019</org_study_id>
    <nct_id>NCT02587013</nct_id>
  </id_info>
  <brief_title>Comparison of Uterine Repair Methods for Cesarean Delivery</brief_title>
  <official_title>Randomized Controlled Trial of Uterine Exteriorization Versus in Situ Repair for Elective Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maisonneuve-Rosemont Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maisonneuve-Rosemont Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to compare the exteriorization of the uterus versus the in situ repair
      for closure of the hysterotomy incision with a completely standardized anesthetic protocol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two well-known uterine repair techniques are described; the uterus can be repaired in situ
      within the peritoneal cavity (intraabdominal) or exteriorized temporarily from the abdomen
      for the closure of the hysterotomy incision (extraabdominal). 3 meta-analysis on the topic
      were unable to demonstrate the superiority of one technique regarding maternal morbidities.
      However, there is a paucity of studies with a standardized anesthetic protocol evaluating
      these outcomes.

      This study will evaluate the impact of the uterine repair technique on different maternal
      morbidities; focusing on intra-operative nausea and vomiting under a standardized anesthetic
      protocol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of intraoperative nausea and vomiting</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Incidence of intraoperative nausea and vomiting using a scale of 0 to 3; 0 being no nausea, 1 being light nausea, 2 being severe nausea, and 3 being nausea accompanied with vomiting and / or retching.
The patients will be questioned at 5 pre-determined time points during the cesarean delivery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Hypotensive episodes, defined as a difference of more than 20% of the baseline mean arterial pressure, despite a phenylephrine infusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic irrigation</measure>
    <time_frame>Intraoperative</time_frame>
    <description>To determine if the patient had pelvic irrigation, yes or no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of surgery</measure>
    <time_frame>Intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated blood loss</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Measuring suction canisters and wet sponges</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in hemoglobin</measure>
    <time_frame>Within 24 hours of surgery</time_frame>
    <description>Difference between preoperative and postoperative hemoglobin within 24 hours of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of endometritis</measure>
    <time_frame>Through study completion; on average of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to return of bowel function</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>The return of bowel function will be assessed by listening to each of the four abdominal quadrants for intestinal peristalsis with a stethoscope twice a day and by assessing the time of the first gas or bowel movement. The first occurrence of any of these events will determine the return of intestinal transit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay after the cesarean delivery</measure>
    <time_frame>Through study completion on average of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of tachycardia</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Tachycardia, defined as a heart rate above 100 beats per minute</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Complications; Cesarean Section</condition>
  <arm_group>
    <arm_group_label>In situ uterine repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The uterus is repaired in situ within the abdominal cavity, without exteriorization; intra-abdominal repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exteriorization of the uterus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The uterine incision is repaired with the exteriorization of the uterus; extra-abdominal repair</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Type A of uterine repair: In situ</intervention_name>
    <description>The uterine incision is closed with the uterus within the abdominal cavity</description>
    <arm_group_label>In situ uterine repair</arm_group_label>
    <other_name>Intra-abdominal uterine repair</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Type B of uterine repair: Exteriorization</intervention_name>
    <description>The uterine incision is repaired with the exteriorization of the uterus</description>
    <arm_group_label>Exteriorization of the uterus</arm_group_label>
    <other_name>Extra-abdominal uterine repair</other_name>
    <other_name>Exteriorisation of the uterus</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective cesarean delivery

          -  Term gestation, 37 weeks or more

          -  Healthy parturients (ASA 1 and 2)

          -  Spinal anesthesia

        Exclusion Criteria:

          -  Conditions at risk of uterine atony and/or postpartum hemorrhage (multiple gestation,
             placenta accrete / previa, pre-eclampsia / eclampsia, uterine leiomyomata,
             polyhydramnios)

          -  Morbid obesity (BMI &gt; 35 kg / m2) at delivery

          -  Coagulopathy

          -  Active labor

          -  Cardiomyopathy

          -  Emergency cesarean section

          -  Refusal/Inability to consent

          -  Language other than English or French
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valerie Zaphiratos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maisonneuve-Rosemont Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valerie Zaphiratos, MD</last_name>
    <email>valerie@zaphiratos.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Danny Mireault, MD</last_name>
    <email>danny.mireault@umontreal.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maisonneuve-Rosemont Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Zaphiratos, MD</last_name>
      <email>valerie@zaphiratos.ca</email>
    </contact>
    <contact_backup>
      <last_name>Danny Mireault, MD</last_name>
      <email>danny.mireault@umontreal.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2015</study_first_submitted>
  <study_first_submitted_qc>October 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2015</study_first_posted>
  <last_update_submitted>September 21, 2016</last_update_submitted>
  <last_update_submitted_qc>September 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maisonneuve-Rosemont Hospital</investigator_affiliation>
    <investigator_full_name>Valerie Zaphiratos</investigator_full_name>
    <investigator_title>Clinical associate professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

